A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Based on Adeno-Associated Virus
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults | PLOS
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness | Science Translational Medicine
![Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies | Journal of Virology Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies | Journal of Virology](https://journals.asm.org/cms/asset/4059aafe-48c3-4eaf-b12e-69f5c6ce7993/jvi.2014.88.issue-5.largecover.jpg)
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies | Journal of Virology
![Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1 | Journal of Virology Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1 | Journal of Virology](https://journals.asm.org/cms/asset/139b27bd-dd3e-4912-8d8e-4fc300ecc322/jvi.2010.84.issue-16.largecover.jpg)